Related Experiment Video

Updated: Jul 17, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

A novel platform for accelerated pharmacodynamic profiling for lead optimization of anticancer drug candidates

Jeffrey Szwaya1, Charles Bruseo, Enkeleda Nakuci

  • 1ArQule Inc, Department of Molecular Oncology, Woburn, MA 01801, USA.

Journal of Biomolecular Screening
|January 30, 2007
PubMed

Insights

A new platform accelerates oncology drug discovery by efficiently characterizing hundreds of high-throughput screening (HTS) hits using Western blot assays. This innovation improves lead optimization and data quality for anticancer drug development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Oncology drug discovery relies heavily on high-throughput screening (HTS) for identifying anticancer leads.
  • Increased HTS efficiency has led to a bottleneck in secondary screening and pharmacodynamic profiling.
  • Characterizing numerous HTS hits requires robust and efficient assay platforms.

Purpose of the Study:

  • To implement a novel platform for efficient characterization of HTS hits using Western blot-based pharmacodynamic assays.
  • To reduce the cycle time for HTS hit evaluation in oncology drug discovery.
  • To improve the quality of data for lead optimization through structure-activity relationship development.

Main Methods:

  • Development and implementation of the Accelerated Pharmaco-Dynamic Profiler (APDP) platform.
  • Utilizing a flatbed bufferless SDS-PAGE system, dry ultra-rapid electroblotting, and infrared imaging.
  • Application of the APDP to annotate inhibitors of BRAF kinase and Hsp90.

Main Results:

  • Significant reduction in the cycle time for HTS hit evaluation.
  • Generation of higher quality data enabling improved lead optimization.
  • Successful annotation of inhibitors for key oncology targets, BRAF kinase and Hsp90.

Conclusions:

  • The APDP platform offers an efficient solution for characterizing HTS hits in oncology drug discovery.
  • This platform enhances data quality and accelerates the development of structure-activity databases.
  • The APDP facilitates the identification and optimization of novel anticancer therapeutics.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...